ENTITY
SanBio Co Ltd

SanBio Co Ltd (4592 JP)

57
Analysis
Health Care • Japan
Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.
more
bullish•SanBio Co Ltd
•16 Dec 2024 18:00•Issuer-paid

SanBio Co Ltd (4592 JP): Q3 FY01/25 flash update

In cumulative Q3 FY01/25, SanBio reported no operating revenue, with an operating loss of JPY2.5bn, narrowing YoY. Non-operating income was...

Logo
368 Views
Share
bullish•SanBio Co Ltd
•17 Sep 2024 18:00•Issuer-paid

SanBio Co Ltd (4592 JP): 1H FY01/25 flash update

In 1H FY01/25, the company reported no operating revenue, an operating loss of JPY1.6bn, and R&D expenses of JPY1.0bn. Non-operating income...

Logo
363 Views
Share
x